Form 8-K - Current report:
SEC Accession No. 0001493152-17-010798
Filing Date
2017-09-21
Accepted
2017-09-21 08:00:38
Documents
3
Period of Report
2017-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 26819
2 ex10-1.htm EX-10.1 23174
3 image_001.jpg GRAPHIC 4709
  Complete submission text file 0001493152-17-010798.txt   57913
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 171095100
SIC: 2834 Pharmaceutical Preparations